David J Cohen

Summary

Affiliation: Saint Luke's Hospital
Country: USA

Publications

  1. doi request reprint Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention
    Steven P Marso
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, 4401 Wornall Rd, Kansas City, MO 64111, USA
    JAMA 303:2156-64. 2010
  2. doi request reprint Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery
    David J Cohen
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    N Engl J Med 364:1016-26. 2011
  3. pmc Interpreting the results of cost-effectiveness studies
    David J Cohen
    Saint Luke s Mid America Heart Institute, Kansas City, Missouri 64111, USA
    J Am Coll Cardiol 52:2119-26. 2008
  4. doi request reprint Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial
    David J Cohen
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City School of Medicine, Kansas City, Missouri 64111, USA
    Catheter Cardiovasc Interv 79:198-209. 2012
  5. pmc Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial)
    David J Cohen
    Saint Luke s Mid America Heart and Vascular Institute, 4401 Wornall Road, Kansas City, MO 64111, USA
    J Am Coll Cardiol 58:1557-65. 2011
  6. doi request reprint Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry
    Lakshmi Venkitachalam
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, School of Medicine, 4401 Wornall Rd, Kansas City, MO 64111, USA
    Circulation 124:1028-37. 2011
  7. doi request reprint Carotid artery stenting of a contralateral occlusion and in-hospital outcomes: results from the CARE (Carotid Artery Revascularization and Endarterectomy) registry
    Nestor Mercado
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, 4401 Wornall Road, Kansas City, MO 64111, USA
    JACC Cardiovasc Interv 6:59-64. 2013
  8. doi request reprint Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trial
    Elizabeth M Mahoney
    Cardiovascular Research Center, Saint Luke s Mid America Heart and Vascular Institute, Kansas City, Missouri, USA
    Catheter Cardiovasc Interv 77:463-72. 2011
  9. doi request reprint Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 2:344-53. 2009
  10. doi request reprint Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B)
    Matthew R Reynolds
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City School of Medicine, Kansas City, MO 64111, USA
    Circulation 125:1102-9. 2012

Detail Information

Publications41

  1. doi request reprint Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention
    Steven P Marso
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, 4401 Wornall Rd, Kansas City, MO 64111, USA
    JAMA 303:2156-64. 2010
    ..The association between the use of bleeding avoidance strategies and post-PCI bleeding as a function of a patient's preprocedural risk of bleeding is unknown...
  2. doi request reprint Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery
    David J Cohen
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    N Engl J Med 364:1016-26. 2011
    ..The effect of PCI with the use of drug-eluting stents on these outcomes is unknown...
  3. pmc Interpreting the results of cost-effectiveness studies
    David J Cohen
    Saint Luke s Mid America Heart Institute, Kansas City, Missouri 64111, USA
    J Am Coll Cardiol 52:2119-26. 2008
    ..Illustrative examples from the cardiology literature are discussed...
  4. doi request reprint Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial
    David J Cohen
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City School of Medicine, Kansas City, Missouri 64111, USA
    Catheter Cardiovasc Interv 79:198-209. 2012
    ..To evaluate the cost-effectiveness of alternative approaches to revascularization for patients with three-vessel or left main coronary artery disease (CAD)...
  5. pmc Health-related quality of life after carotid stenting versus carotid endarterectomy: results from CREST (Carotid Revascularization Endarterectomy Versus Stenting Trial)
    David J Cohen
    Saint Luke s Mid America Heart and Vascular Institute, 4401 Wornall Road, Kansas City, MO 64111, USA
    J Am Coll Cardiol 58:1557-65. 2011
    ..The purpose of this study was to compare health-related quality of life (HRQOL) outcomes in patients treated with carotid artery stenting (CAS) versus carotid endarterectomy (CEA)...
  6. doi request reprint Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry
    Lakshmi Venkitachalam
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, School of Medicine, 4401 Wornall Rd, Kansas City, MO 64111, USA
    Circulation 124:1028-37. 2011
    ..Although the benefits of drug-eluting stents (DES) for reducing restenosis after percutaneous coronary intervention are well established, the impact of alternative rates of DES use on population-level outcomes is unknown...
  7. doi request reprint Carotid artery stenting of a contralateral occlusion and in-hospital outcomes: results from the CARE (Carotid Artery Revascularization and Endarterectomy) registry
    Nestor Mercado
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, 4401 Wornall Road, Kansas City, MO 64111, USA
    JACC Cardiovasc Interv 6:59-64. 2013
    ..The authors sought to study the characteristics and outcomes of patients with contralateral carotid artery occlusions (CCOs) undergoing elective carotid artery stenting (CAS)...
  8. doi request reprint Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at increased surgical risk: results from the SAPPHIRE trial
    Elizabeth M Mahoney
    Cardiovascular Research Center, Saint Luke s Mid America Heart and Vascular Institute, Kansas City, Missouri, USA
    Catheter Cardiovasc Interv 77:463-72. 2011
    ..To evaluate the cost-effectiveness of carotid stenting vs. carotid endarterectomy using data from the SAPPHIRE trial...
  9. doi request reprint Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 2:344-53. 2009
    ..Angina in patients with coronary artery disease is associated with worse quality of life; however, the relationship between angina frequency and resource utilization is unknown...
  10. doi request reprint Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B)
    Matthew R Reynolds
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City School of Medicine, Kansas City, MO 64111, USA
    Circulation 125:1102-9. 2012
    ....
  11. pmc Costs and cost-effectiveness of carotid stenting versus endarterectomy for patients at standard surgical risk: results from the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)
    Katherine R Vilain
    Saint Luke s Mid America Heart Institute, 4401 Wornall Road, Kansas City, MO 64111, USA
    Stroke 43:2408-16. 2012
    ..Given the large number of patients who are candidates for these procedures, an understanding of their relative cost and cost-effectiveness may have important implications for health care policy and treatment guidelines...
  12. doi request reprint Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry)
    Amit P Amin
    Saint Luke s Mid America Heart and Vascular Institute, Kansas City, Missouri, USA
    Am J Cardiol 107:1751-6. 2011
    ..3%, p = 0.26). In conclusion, among unselected patients undergoing elective PCI with bivalirudin as the planned anticoagulant, clopidogrel pretreatment was common but was not associated with a reduced risk of ischemic complications...
  13. doi request reprint Association between bleeding events and in-hospital mortality after percutaneous coronary intervention
    Adnan K Chhatriwalla
    Department of Biostatistics, Saint Luke sMid America HeartInstitute, Kansas City, Missouri 64111, USA
    JAMA 309:1022-9. 2013
    ..The incidence of bleeding-related mortality after PCI has not been described in a nationally representative population. Furthermore, the relationships among bleeding risk, bleeding site, and mortality are unclear...
  14. doi request reprint Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons
    Suzanne V Arnold
    St Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 5:267-75. 2012
    ....
  15. doi request reprint Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry
    Jason B Lindsey
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    Circ Cardiovasc Interv 4:474-80. 2011
    ....
  16. doi request reprint Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial)
    Amit P Amin
    Saint Luke s Mid America Heart Institute, Kansas City, MO, USA
    Am J Cardiol 110:765-70. 2012
    ..These findings demonstrate that in patients undergoing percutaneous coronary intervention with DESs, use of EESs is economically attractive compared to PESs with improved clinical outcomes and lower overall medical care costs at 2 years...
  17. doi request reprint Survival benefit with drug-eluting stents in observational studies: fact or artifact?
    Lakshmi Venkitachalam
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City School of Medicine, 4401 Wornall Road, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 4:587-94. 2011
    ....
  18. doi request reprint Predicting restenosis of drug-eluting stents placed in real-world clinical practice: derivation and validation of a risk model from the EVENT registry
    Joshua M Stolker
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Interv 3:327-34. 2010
    ..Prediction of restenosis after percutaneous coronary intervention (PCI) remains challenging, and existing risk assessment algorithms were developed before the widespread adoption of drug-eluting stents (DES)...
  19. doi request reprint The impact of bivalirudin on percutaneous coronary intervention-related bleeding
    Jason B Lindsey
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO, USA
    EuroIntervention 6:206-13. 2010
    ..We studied the clinical and economic impact of bivalirudin in clinical practice...
  20. doi request reprint Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial
    Mouin S Abdallah
    Saint Luke s Mid America Heart Institute, Kansas City, Missouri 64111, USA
    JAMA 310:1581-90. 2013
    ..Whether there are treatment differences in health status, as assessed from the patient's perspective, is unknown...
  21. doi request reprint Selecting antiplatelet therapy at the time of percutaneous intervention for an acute coronary syndrome: weighing the benefits and risks of prasugrel versus clopidogrel
    Adam C Salisbury
    Saint Luke s Mid America Heart and Vascular Institute, and University of Missouri Kansas City, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 6:27-34. 2013
    ..We developed predictive models of the benefits (reduced ischemic events) and risks (increased bleeding) to support targeting prasugrel to those who benefit most from treatment...
  22. doi request reprint In-hospital outcomes and cost comparison of femoropopliteal reopening strategies
    David M Safley
    Saint Luke s Mid America Heart Institute, St Luke s Hospital, Kansas City, MO 64111, USA
    Cardiovasc Revasc Med 12:292-8. 2011
    ..Despite increasing use of atherectomy (and higher cost of atherectomy catheters compared with balloon catheters), few studies have compared outcomes and costs with other reopening strategies...
  23. doi request reprint Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry
    Jason B Lindsey
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, Missouri 64111, USA
    JACC Cardiovasc Interv 2:1074-82. 2009
    ..Our aim was to examine the prognostic importance of hemorrhagic and ischemic complications after percutaneous coronary intervention (PCI) in unselected patients...
  24. doi request reprint Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasug
    Elizabeth M Mahoney
    Saint Luke s Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO 64111, USA
    Circulation 121:71-9. 2010
    ..We evaluated the cost-effectiveness of prasugrel versus clopidogrel from the perspective of the US healthcare system by using data from TRITON-TIMI 38...
  25. doi request reprint Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Heart Fail 6:61-7. 2013
    ..However, its psychometric properties have not yet been evaluated in these patients...
  26. doi request reprint Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 1:107-15. 2008
    ..Ranolazine has been shown to reduce myocardial ischemia and symptom severity among selected patients with chronic angina. However, data regarding the effect of ranolazine on health status/quality of life (QOL) are limited...
  27. doi request reprint Cost-effectiveness of targeting patients undergoing percutaneous coronary intervention for therapy with bivalirudin versus heparin monotherapy according to predicted risk of bleeding
    Amit P Amin
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 3:358-65. 2010
    ....
  28. pmc Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial
    Elizabeth A Magnuson
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circulation 127:820-31. 2013
    ..Whether these results apply in the drug-eluting stent (DES) era is unknown...
  29. ncbi request reprint Cost-effectiveness of alternative approaches to the management of chronic obstructive coronary artery disease
    Amit P Amin
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO, USA
    Rev Cardiovasc Med 10:S3-13. 2009
    ....
  30. doi request reprint Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States
    Elizabeth M Mahoney
    Saint Luke s Mid America Heart and Vascular Institute, Kansas City, MO, USA
    Circ Cardiovasc Qual Outcomes 3:642-51. 2010
    ....
  31. doi request reprint Health-related quality of life following carotid stenting versus endarterectomy: results from the SAPPHIRE (Stenting and Angioplasty with Protection in Patients at HIgh Risk for Endarterectomy) trial
    Joshua M Stolker
    Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, Missouri, USA
    JACC Cardiovasc Interv 3:515-23. 2010
    ..This study compared health-related quality of life in patients undergoing carotid artery stenting (CAS) versus surgical endarterectomy (CEA)...
  32. doi request reprint Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance
    Lakshmi Venkitachalam
    University of Missouri Kansas City School of Medicine, Kansas City, MO, USA
    Circulation 125:1858-69. 2012
    ..An understanding of the relationship between country-level economic and health system factors and elevated cholesterol may provide insight for prioritization of cardiovascular prevention programs...
  33. doi request reprint The impact of dyspnea on health-related quality of life in patients with coronary artery disease: results from the PREMIER registry
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO, USA
    Am Heart J 157:1042-9.e1. 2009
    ..Both angina and dyspnea are prevalent symptoms among post-myocardial infarction (MI) patients. Given their frequent overlap, little is known about the degree to which these symptoms provide independent information in this population...
  34. doi request reprint Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry)
    Andrew D Frutkin
    Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO 64111, USA
    JACC Cardiovasc Interv 2:614-21. 2009
    ..Our purpose was to evaluate percutaneous coronary intervention (PCI) attempt rates in patients with class I indications for coronary artery bypass graft (CABG) surgery after the introduction of drug-eluting stents (DES)...
  35. ncbi request reprint Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry
    John A Spertus
    MPH, Mid America Heart Institute, 4401 Wornall Rd, Kansas City, MO 64111
    Circulation 113:2803-9. 2006
    ..The rate and consequences of prematurely discontinuing thienopyridine therapy after DES placement for acute myocardial infarction (MI) are unknown...
  36. pmc Concordance of physician ratings with the appropriate use criteria for coronary revascularization
    Paul S Chan
    Saint Luke s Mid America Heart Institute, Kansas City, Missouri 64111, USA
    J Am Coll Cardiol 57:1546-53. 2011
    ..The objective of this study was to compare the consistency in appropriate use criteria (AUC) ratings among a broad range of practicing cardiologists and the AUC Technical Panel...
  37. doi request reprint Cost-effectiveness of oral antiplatelet agents--current and future perspectives
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, 4401 Wornall Road, Kansas City, MO 64111, USA
    Nat Rev Cardiol 8:580-91. 2011
    ....
  38. doi request reprint One-year costs in patients with a history of or at risk for atherothrombosis in the United States
    Elizabeth M Mahoney
    Saint Luke s Mid America Heart Institute, Kansas City, MO 64111, USA
    Circ Cardiovasc Qual Outcomes 1:38-45. 2008
    ....
  39. doi request reprint How to define a poor outcome after transcatheter aortic valve replacement: conceptual framework and empirical observations from the placement of aortic transcatheter valve (PARTNER) trial
    Suzanne V Arnold
    Saint Luke s Mid America Heart Institute, Kansas City, MO
    Circ Cardiovasc Qual Outcomes 6:591-7. 2013
    ..We sought to evaluate potential definitions of a poor outcome after TAVR that combine both mortality and quality of life components...
  40. doi request reprint Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial
    John A Spertus
    Department of Cardiovascular Research, Saint Luke s Mid America Heart Institute, University of Missouri Kansas City, Kansas City, MO, USA
    Circ Cardiovasc Qual Outcomes 6:409-18. 2013
    ..The predictors and outcomes of patients who crossed over from OMT to revascularization are unknown...
  41. ncbi request reprint Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial
    Gregory G Pellizzon
    Mid America Heart Institute, Saint Luke s Hospital, Kansas City, Missouri, USA
    J Am Coll Cardiol 43:1368-74. 2004
    ..We sought to determine the prognostic importance of mitral regurgitation (MR) in patients undergoing percutaneous coronary intervention for acute myocardial infarction (AMI)...